No effects were seen in terms of satiety (leptin) and insulin resistance (insulin and resistin), or in inflammatory markers (tumor necrosis factor-α, monocyte chemotactic protein-1, and interleukin-6). The gene discussed is RETN; the disease is Insulin resistance.